Health and Healthcare

Monday's Top Biotech and Medical Stocks

From BioHealth Investor

Biotechnology

NEURO-HITECH INC [NHPI.OB] +17.36%
LEV PHARMACEUTICALS [LEVP.OB] +11.18%
OBAGI MEDICAL [OMPI] +9.16%
GENVEC INC [GNVC] +7.84%
ACHILLION PHARMACEUT [ACHN] +6.71%

Diagnostic Substances

SCOLR PHARMA INC [DDD] +8.00%
LEXICON GENETICS I [LEXG] +6.97%
ASPENBIO PHARMA INC [APNB.OB] +6.12%
ABAXIS INC [ABAX] +5.98%
ICAGEN, INC. [ICGN] +5.32%

Drug Delivery

FLAMEL TECH SA ADR [FLML] +11.22%
INSITE VISION INC [ISV] +7.55%
QUIGLEY CORP THE [QGLY] +3.79%
DELCATH SYSTEMS INC [DCTH] +3.77%
K V PHARMA CL A [KV-A] +2.85%

Drug Manufacturers

PHARMAXIS LTD ADR [PXSL] +9.69%
NITROMED, INC. [NTMD] +7.99%
ADVANCIS PHARMA CP [AVNC] +5.95%
BRADLEY PHARMACTCL [BDY] +5.70%
ATHEROGENICS INC [AGIX] +5.56%

Medical Appliances & Equipment

SYNOVIS LIFE TECH [SYNO] +5.76%
ROCKWELL MED TECHS [RMTI] +4.97%
ALPHA PRO TECH [APT] +4.91%
NORTH AMERN SCI [NASI] +4.85%
SPECTRASCIENCE NEW [SCIE.OB] +4.72%

Medical Instruments & Supplies

NEPHROS INC. [NEP] +22.85%
OCCULOGIX, INC. [OCCX] +21.33%
MICROMED CARDIOVASCU [MMCV.OB] +14.29%
IMMUNOCELLULAR THERA [IMUC.OB] +13.04%
BIOMIMETIC THERAPEUT [BMTI] +9.97%

Medical Laboratories & Research

MEDTOX SCIENTFIC INC [MTOX] +6.38%
RADNET INC [RDNT.OB] +3.68%
ERESEARCHTECHNOLOG [ERES] +2.87%
GENOMIC HEALTH, INC. [GHDX] +2.83%
QUEST DIAGNOSTC [DGX] +1.61%

http://www.biohealthinvestor.com/

Sponsored: Want to Retire Early? Here’s a Great First Step

Want retirement to come a few years earlier than you’d planned? Orare you ready to retire now, but want an extra set of eyes on your finances?

Now you can speak with up to 3 financial experts in your area for FREE. By simply clicking here you can begin to match with financial professionals who can help you build your plan to retire early. And the best part? The first conversation with them is free.

Click here to match with up to 3 financial pros who would be excited to help you make financial decisions.

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.